Folate absorption in women with a history of neural tube defect–affected pregnancy
Open Access
- 1 July 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 72 (1) , 154-158
- https://doi.org/10.1093/ajcn/72.1.154
Abstract
Background: The risk of neural tube defects (NTDs) is significantly reduced by supplemental folic acid. NTD risk may be associated with impaired absorption of polyglutamyl folate, the primary form of naturally occurring food folate, and of folic acid in supplements or fortified food. Stable-isotope methods provide the specificity needed to test this hypothesis. Objective: We determined whether women who had an NTD-affected pregnancy had a reduced ability compared with control women to absorb polyglutamyl folate relative to folic acid. Design: Healthy, nonpregnant women with a history of an NTD-affected pregnancy (cases; n = 11) and control women (n = 11) were administered an oral dose containing a mixture of [2H]pteroylpentaglutamate ([2H2]PteGlu5; 233 nmol) and [13C]pteroylmonoglutamate ([13C5]PteGlu1; 567 nmol) after a 30-d saturation protocol (2 mg unlabeled folic acid/d). Relative extents of absorption were evaluated by urinary excretion of 2H2- and 13C5-labeled folates 48 h postdose. Results: During the first 24 h postdose, cases excreted less (x̄ ± SD) [2H2]PteGlu5 (21 ± 12% compared with 37 ± 19%; P = 0.01) and [13C5]PteGlu1 (17 ± 8% compared with 31 ± 14%; P = 0.007) than did controls. No significant differences between cases and controls were detected in the percentage of [2H2]PteGlu5 or [13C5]PteGlu1 excreted during the second 24 h postdose or when the data were averaged over 48 h. However, excretion of the [2H2]folates tended to be lower in cases than in controls over the 48-h period (33 ± 13% compared with 45 ± 26%; P = 0.21). A similar trend (P = 0.29) for lower excretion of [13C5]folates in cases was also observed (31 ± 16% compared with 39 ± 17%). The ratio of urinary [2H2]folates to [13C5]folates did not differ significantly between cases and controls. Conclusion: These data suggest the need for a larger-scale study using stable-isotope methods to further investigate this hypothesis.Keywords
This publication has 17 references indexed in Scilit:
- Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate RequirementJournal of Nutrition, 1999
- Absorption of Dietary and Supplemental Folate in Women with Prior Pregnancies with Neural Tube Defects and ControlsJournal of the American College of Nutrition, 1998
- Preparation of stable isotopically labeled folates for in vivo investigation of folate absorption and metabolismPublished by Elsevier ,1997
- PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTSEpidemiology, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Investigation of folate intake and metabolism in women who have had two pregnancies complicated by neural tube defectsBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Absorption of pteroylpolyglutamates in mothers of infants with neural tube defectsBritish Journal of Nutrition, 1993
- Possible Abnormalities of Folate and Vitamin B12 Metabolism Associated with Neural Tube DefectsaAnnals of the New York Academy of Sciences, 1993
- Chemical synthesis of deuterated folate monoglutamate and in vivo assessment of urinary excretion of deuterated folates in manAnalytical Biochemistry, 1988
- Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects?Clinical Genetics, 1987